Tyronib (imatinib mesylate) 400mg gallary

Tyronib® (Imatinb Mesylate) 400mg ⇒ Product Glimpse

Tyronib® (Imatinb Mesylate) 400mg ⇒ 10 Tab

Tyronib (Imatinib Mesylate) - 400mg (10 Tablets)
Tyronib (Imatinib Mesylate) - 400mg (10 Tablets)
Tyronib (Imatinib) - 400mg (10 Tablets)
Tyronib Imatinib Mesylate Tablet 400mg
Tyronib Imatinib Mesylate 400 Mg Tablet Taj Pharma Packaging Info
Imatinib mesylate 400mg tablet

Tyronib® (Imatinb Mesylate) 400mg ⇒ 10X10 Tab

Tyronib (Imatinib) 400mg Tablets
Tyronib Imatinib Mesylate drug description chemical structure black box warning medications drugs generic fda approved patient labeling reviews professionals clinicians clinical
Tyronib imatinib
Consumer information about the medication imatinib (Tyronib),
Tyronib Imatinib 400mg Tablets

Tyronib® (Imatinb Mesylate) 400mg ⇒ 30 Tabs Bottle

Tyronib® (Imatinib Mesylate Tablets) used to treat certain types of leukemia and other cancers of the blood cells
Imatinib 400mg tablets
imatinib manufacturing, imatinib India
IMATINIB, tablets, 100 mg and 400 mg
imatinib mesylate tablets 100mg , 400mg  manufacturer Imatinib Mesylate Tablets)
Imatinib, tablets, 100 mg and 400 mg (as mesylate)

Generic Pack

Imatinb Mesylate 400mg ⇒ 10 Tab

Tyronib® Imatinib Mesylate 400mg tablets leukaemias (acute)
Imatinib mesylate
(Imatinib Mesylate) - 400mg (10 Tablets)
(Imatinib Mesylate) - 400mg (10 Tablets)
imatinib mesylate tablets manufacturer imatinib mesylate tablets supplier imatinib mesylate
Tyronib (Imatinib Mesylate)

Imatinb Mesylate 400mg ⇒ 10x10 Tab

Imatinib 400mg tablets
Imatinib 400mg tablets 10x10
Tyronib® Imatinib Mesylate) 400mg
Tyronib (imatinib mesylate) 400mg 10x10 tab
imatinib prices
400 mg of imatinib

Imatinb Mesylate 400mg ⇒ 30 Tabs Bottle

imatinib product
imatinib 400 mg bottle
Tyronib 400 mg Tablets - 30 Tablet Bottle
Tyronib 400 mg Tablets - 30 Tablet Bottle
Generic imatinib mesylate tablets
imatinib 400mg otc bottle


Tyronib® (Imatinb Mesylate), is a targeted therapy used to treat certain types of Leukaemia and soft tissue sarcoma, it may also be used to treat other types of cancers as part of research trial.

Tyronib® (Imatinib Mesylate) may be used to treat:

  • Chronic myeloid leukaemia (CML)
  • A type of acute lymphoblastic leukaemia (ALL) called Philadelphia chromosome positive (Ph+ ALL)
  • Gastro-intestinal stromal tumours (GISTs)
  • A rare type of soft tissue cancer called dermatofibrosarcoma protuberans (DFSP)
  • Other types of cancers as part of a research trial.

Important Safety Information

  • Pregnancy Category D:Imatinib can cause fetal harm when administered to a pregnant woman. There have been post-market reports of spontaneous abortions and infant congenital anomalies from women who have taken Imatinib.

    There are no adequate and well-controlled studies with Imatinib in pregnant women. Women should be advised not to become pregnant when taking Imatinib. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus.

  • Nursing Mothers:Imatinib and its active metabolite are excreted into human milk. Based on data from three breastfeeding women taking Imatinib, the milk:plasma ratio is about 0.5 for imatinib and about 0.9 for the active metabolite.

  • Pediatric Use:Imatinib safety and efficacy have been demonstrated in children with newly diagnosed Ph+ chronic phase CML and Ph+ ALL. There are no data in children under 1 year of age.

  • Geriatric Use: In the CML clinical studies, approximately 20% of patients were older than 65 years. In the study of patients with newly diagnosed CML, 6% of patients were older than 65 years. No difference was observed in the safety profile in patients older than 65 years as compared to younger patients, with the exception of a higher frequency of edema. The efficacy of Imatinib was similar in older and younger patients.

Patient Information  
Full Prescribing Information